Q9989 Ustekinumab, for intravenous injection, 1 mg

Short descriptor: Ustekinumab, iv inject,1 mg

⚠ Terminated HCPCS Level II 2026
Terminated Code
Q9989 was terminated as of 2017-12-31 and should not be reported for dates of service after that date. This page is retained for historical reference.
Open Q9989 in the app →

Look up Q9989 alongside ICD-10-CM diagnoses, the HCPCS Table of Drugs, and the AI coding assistant.

Q9989 is the HCPCS Level II code for Ustekinumab, for intravenous injection, 1 mg (2026). It belongs to Section Q — Temporary Codes. Under Medicare, its coverage status is: Carrier judgment. Part B pricing methodology: Drugs.

Classification & CMS Attributes

Medicare Coverage
Carrier judgment (code C)
Part B Pricing
Drugs (indicator 51)
Type of Service
Medical care
Effective Date
2018-01-01
Termination Date
2017-12-31
2026 Maintenance
No change this year

References

Cite This Page

Reference Q9989 with the canonical source and edition:

Q9989 — Ustekinumab, for intravenous injection, 1 mg. ICD-10 Coding Pro (HCPCS Level II 2026). https://icd10codingpro.com/hcpcs-codes/Q9989

Canonical URL: https://icd10codingpro.com/hcpcs-codes/Q9989

Related Codes in Section Q

← Q9988 Platelets, pathogen reduced Q9991 → Buprenorph xr 100 mg or less
Q9985 Inj hydroxyprogst capoat nos Q9986 Makena, 10 mg Q9987 Pathogen test for platelets Q9988 Platelets, pathogen reduced Q9991 Buprenorph xr 100 mg or less Q9992 Buprenorphine xr over 100 mg Q9993 Inj., triamcinolone ext rel Q9994 Enzyme cartridge enteral nut Q9995 Inj., emicizumab-kxwh 0.5 mg Q9996 Ustekinumab- ttwe sub cu inj
Browse all HCPCS Level II sections →
Reviewed by Prajwal Shrestha, CPC, CRC
Certified Professional Coder (CPC) and Certified Risk Adjustment Coder (CRC) · AAPC Member ID 01997614 · About · Editorial policy · Content last reviewed: 2026-01-01

Get HCC Mappings, Clinical Summaries, and More

Access premium features including HCC risk adjustment, FDA drug indications, AI coding assistant, and comprehensive clinical context.

Start Free Trial